Professor of Medicine @JohnsHopkins, HIV Clinical Researcher, wife, mom. Views and opinions expressed here are mine alone.
Baltimore, MD
Joined June 2009
- Tweets458
- Following552
- Followers507
- Likes1.4K
Kelly Gebo retweeted
Chairman of @HouseAppropsGOP Subcommittee on Labor, Health and Human Services, and Education @Robert_Aderholt understands the #valueofID.
Thank you, Chairman Aderholt, for your support.
Terrific work, @Ewrhiker! It's wonderful to see mentees become successful independent investigators. Congratulations!
Thank you @kgebo @pssinatl and @CarlosdelRio7 for helping prepare me to be a thought leader on the national stage with systems thinking in medicine
#healthsystemsscience #ipe
4
Kelly Gebo retweeted
Study from @HopkinsMedicine shows #Paxlovid can safely be used to reduce risk of severe #COVID19 in people who are pregnant. @JAMANetworkOpen @willgarneau @IrinaBurd @kgebo @JHMed_ID hopkinsmedicine.org/news/new… via @HopkinsMedNews
I have been inspired by too many women to count through my education, at work, and in my community. I am grateful for them all.
But my two biggest inspirations are my mom and daughter. Thank you for giving me the reason to go the extra mile. Love you both. ❤️
1
8
Kelly Gebo retweeted
People in need antiviral treatments for COVID-19 may not be receiving it because of where they live.
IDSA & @HIVMA urge the federal government, health care systems, public health officials & clinicians to take additional steps to ensure equitable access: bit.ly/3naoRST
So proud to work with this outstanding team on this important project!
@KleinLab @jhDavidSullivan @sabraklein1998 @ACasadevall1 @ShohamTxID @AndreaCoxMDPhD @andrewpekosz @EmilySpivak
@HopkinsMedNews @JohnsHopkinsDOM @JHMed_ID
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection: buff.ly/3t9SwiT
@kgebo @HopkinsMedicine
#COVID_19 #InfectiousDisease
Kelly Gebo retweeted
For greatest efficacy, COVID-19 convalescent plasma (CP) must be given early & with high titer. The best time may be to outpatients, to prevent disease progression. Here are details on how to set up an outpatient CP operation. @kgebo @ShohamTxID
pubmed.ncbi.nlm.nih.gov/3535…
Kelly Gebo retweeted
Findings published in @NEJM highlight COVID convalescent plasma study by @jhDavidSullivan & @kgebo & team of many collabs including @ACasadevall1 @ShohamTxID
Amazing work! 👋👋👋
publichealth.jhu.edu/2022/jo…
Using convalescent plasma from patients who have recovered from #COVID19, and have antibodies against the virus, is a safe and effective treatment for the virus, according to a recent study by @JohnsHopkinsSPH and @HopkinsMedicine researchers.
publichealth.jhu.edu/2022/jo…
Early Outpatient Treatment for Covid-19 with Convalescent Plasma | NEJM nejm.org/doi/full/10.1056/NE…
Does convalescent plasma work to prevent #COVID19 hospitalization?
YES! Our clinical trial shows #COVID19 convalescent plasma given within 9 days of symptoms reduces hospitalization
We are grateful to the participants and the study team, all who spent many hours around the country to receive and administer CCP or placebo.
This study was funded by the US @DOD_Outreach, #BloombergPhilanthropies, the #StateofMaryland, and @NIH (@NIAID_News, @ncats_nih_gov).
1
NEXT STEPS: High-titer convalescent plasma from people who have been infected with #SARSCoV2 and who are #COVID19 vaccinated is called #VaxPlasma. The antibody levels are more than 3X the antibody levels compared with those who were infected (but not #vaxxed) with #SARSCoV2
Our trial was conducted BEFORE the emergence of #Omicron. However, it is likely high-titer convalescent plasma from those infected with Omicron will also reduce #hospitalizations.
2
5
Thrilled to be celebrating International Womens month with amazing @JohnsHopkinsDOM panel Thank you for the great discussion!
@AmitaGuptaMD @DrDeidraCrews Dr Rachel Levine, Dr Maria Oliva-Hempker and Dr Wendy Bennett
This figure shows the difference in hospitalizations among those who received CP vs. control in this double blind RCT of 1181 participants in the US
#COVID19
medrxiv.org/content/10.1101/…
@DrEricDing @soupvector @andrewpekosz @CarlosdelRio7 @IDSAInfo @AndreaCoxMDPhD @sabraklein1998
Our double-blind, randomized clinical trial (N=1181 participants) showed that those treated with convalescent plasma with high #SARSCoV2 antibody titers had a 2.9% probability of hospitalization, compared to 6.3% in those with placebo control plasma.
2/
ALT Graph shows that control plasma participants had a 6.3% probability of hospitalization and that convalescent plasma participants had a 2.9% probability of hospitalization.
8